Skip to main content
. 2019 Apr 23;8(6):3278–3285. doi: 10.1002/cam4.2187

Figure 2.

Figure 2

Time‐to‐event curves for AKI differed significantly between preexisting and non‐preexisting–CKD (Panel A), serum β2M ≥ 3.7 mg/L and serum β2M < 3.7 mg/L (Panel B), and between mucositis grade 3/4 and non‐mucositis grade 3/4 patients (Panel C) (P < 0.001, P < 0.001 and P = 0.001, respectively, by the log‐rank test). CKD, chronic kidney disease; β2M, β2 microglobulin; AKI, acute kidney injury